P. Colpani

The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients

G. Grasselli, F. Blasi, F. Peyvandi, 2020, Journal of Thrombosis and Haemostasis.

Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease

P. Bucciarelli, F. Peyvandi, L. Baronciani, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients

C. Cordiglieri, F. Peyvandi, L. Baronciani, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparison of von Willebrand factor platelet‐binding activity assays: ELISA overreads type 2B with loss of HMW multimers

R. Montgomery, G. Castaman, F. Peyvandi, 2020, Journal of thrombosis and haemostasis : JTH.

Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation

F. Peyvandi, L. Baronciani, M. T. Pagliari, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays

F. Peyvandi, L. Baronciani, M. T. Pagliari, 2023, Research and practice in thrombosis and haemostasis.

Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2

F. Peyvandi, L. Baronciani, M. T. Pagliari, 2022, Blood advances.